Location: Belgium, Brussels-Capital, City of Brussels
Employees: 11-50
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A; Series B
Portfolio 6
| Date | Name | Website | Total Raised | Location |
| 02.05.2023 | Anavo Ther... | anavotx.co... | $85.32M | Netherland... |
| 06.03.2023 | Bicara The... | bicara.com | $273M | United Sta... |
| 15.10.2022 | Tridek One | tridekone.... | $17.42M | France, Il... |
| - | Primmune T... | primmunerx... | $15.4M | United Sta... |
| - | Enhanc3D G... | enhanc3dge... | $12.72M | United Kin... |
| - | Egle Thera... | egle-tx.co... | - | France, Il... |
Persons 52
| Date | First Name | Last Name | Title | Location | |||
| - | Debora | Dumont | Managing P... | linkedin.c... | - | - | - |
| - | Olivier | Houben | - | linkedin.c... | - | - | - |
| - | Tom | Heyman | - | - | - | - | |
| - | Alexander | Demoulin | Associate | linkedin.c... | - | - | - |
| - | Joris | Vanderloch... | Chief Scie... | linkedin.c... | - | - | - |
| - | Tol | Trimborn | - | linkedin.c... | - | - | - |
| - | Jacques | Mizrahi | - | linkedin.c... | - | - | - |
| - | Janine | Schuurman | - | - | - | - | |
| - | Joris | De Maeyer | Executive ... | linkedin.c... | - | - | - |
| - | Clement | Salque | Junior Ass... | linkedin.c... | - | - | - |
Show more
News 27
| Date | Title | Description |
| 08.02.2024 | Enhanc3D Genomics appoints Dr Daniel Turner as Chief Scienti... | Appointment forms part of ongoing plans for continued development of the GenLink3D genomics platform... |
| 10.01.2024 | Bicara Therapeutics Announces Oversubscribed $165 Million Se... | Proceeds to accelerate clinical development of first-in-class bifunctional EGFR/TGF-β inhibitor, BCA... |
| 01.11.2023 | Bicara Therapeutics Presents Updated Interim Data from Ongoi... | First-in-class bifunctional EGFR/TGF-β inhibitor, BCA101, in combination with pembrolizumab continue... |
| 01.11.2023 | Bicara Therapeutics Expands Board of Directors with Appointm... | Boston, Mass., October 16, 2023 – Bicara Therapeutics, a clinical-stage biotechnology company develo... |
| 01.11.2023 | Primmune Therapeutics to Present New Clinical Data from Phas... | |
| 01.11.2023 | Anavo Therapeutics strengthens management team | The company appoints industry veteran Shaun McNulty as Chief Scientific Officer and welcomes R&D... |
| 04.08.2023 | Bicara Therapeutics Expands Management Team with the Appoint... | CAMBRIDGE, Mass., July 24, 2023 – Bicara Therapeutics, a clinical-stage biotechnology company develo... |
| 07.07.2023 | Bicara Therapeutics’ First-in-class Bifunctional EGFR/TGF-β ... | Phase 1/1b results to be highlighted in an oral presentation at 2023 ASCO Annual Meeting |
| 07.07.2023 | Primmune Therapeutics to Present New Clinical Data from Phas... | SAN DIEGO, March 14, 2023 – Primmune Therapeutics, a biotech company harnessing the power of the inn... |
| 05.05.2023 | Anavo Therapeutics extends Seed Round to EUR 28 Million to A... | Leiden, The Netherlands, and Heidelberg, Germany, May 2, 2023 – Anavo Therapeutics, a global leader ... |
Show more
Mentions in press and media 3
| Date | Title | Description | Source |
| 03.05.2023 | Dutch-based Anavo Therapeutics secures €8.5M to systematical... | Leiden-based Anavo Therapeutics, a company that claims to be the first to systematically drug phosph... | siliconcan... |
| 16.09.2022 | French biotech Tridek-One gets €16 million booster to restor... | Paris-based biotech startup Tridek-One has raised €16 million in funding to speed up its research an... | tech.eu/20... |
| 22.10.2021 | Egle Therapeutics raises 40 million € Series A to develop Fi... | Egle Therapeutics SAS (Egle), an emerging biotechnology company focused on developing First-In- Clas... | fundplus.b... |